Cargando…

Pregnancy does not modify the risk of MS in genetically susceptible women

OBJECTIVE: To use the case-only gene-environment (G [Image: see text] E) interaction study design to estimate interaction between pregnancy before onset of MS symptoms and established genetic risk factors for MS among White adult females. METHODS: We studied 2,497 female MS cases from 4 cohorts in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Cameron J., Wu, Sean L., Shao, Xiaorong, Bradshaw, Patrick T., Gonzales, Edlin, Smith, Jessica B., Xiang, Anny H., Bellesis, Kalliope H., Chinn, Terrence, Bos, Steffan D., Wendel-Haga, Marte, Olsson, Tomas, Kockum, Ingrid, Langer-Gould, Annette M., Schaefer, Catherine, Alfredsson, Lars, Barcellos, Lisa F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673284/
https://www.ncbi.nlm.nih.gov/pubmed/33037103
http://dx.doi.org/10.1212/NXI.0000000000000898
Descripción
Sumario:OBJECTIVE: To use the case-only gene-environment (G [Image: see text] E) interaction study design to estimate interaction between pregnancy before onset of MS symptoms and established genetic risk factors for MS among White adult females. METHODS: We studied 2,497 female MS cases from 4 cohorts in the United States, Sweden, and Norway with clinical, reproductive, and genetic data. Pregnancy exposure was defined in 2 ways: (1) [Image: see text] live birth pregnancy before onset of MS symptoms and (2) parity before onset of MS symptoms. We estimated interaction between pregnancy exposure and established genetic risk variants, including a weighted genetic risk score and both HLA and non-HLA variants, using logistic regression and proportional odds regression within each cohort. Within-cohort associations were combined using inverse variance meta-analyses with random effects. The case-only G × E independence assumption was tested in 7,067 individuals without MS. RESULTS: Evidence for interaction between pregnancy exposure and established genetic risk variants, including the strongly associated HLA-DRB1*15:01 allele and a weighted genetic risk score, was not observed. Results from sensitivity analyses were consistent with observed results. CONCLUSION: Our findings indicate that pregnancy before symptom onset does not modify the risk of MS in genetically susceptible White females.